{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T15:59:16Z","timestamp":1724774356164},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.ijrobp.2017.12.256","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T13:22:53Z","timestamp":1513862573000},"page":"1026-1033","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Associations of Genetic Variations in MicroRNA Seed Regions With Acute Adverse Events and Survival in Patients With Rectal Cancer Receiving Postoperative Chemoradiation Therapy"],"prefix":"10.1016","volume":"100","author":[{"given":"Ying","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shulian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yexiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.12.256_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3322\/caac.21220","article-title":"Colorectal cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib4","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(10)60353-4","article-title":"Colorectal cancer","volume":"375","author":"Cunningham","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/CAD.0b013e3283293fd4","article-title":"Pharmacology and therapeutic efficacy of capecitabine: Focus on breast and colorectal cancer","volume":"20","author":"Aprile","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib6","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"Twelves","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.critrevonc.2010.07.012","article-title":"Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer","volume":"79","author":"Chua","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/nrc1233","article-title":"Cancer pharmacogenetics: Polymorphisms, pathways and beyond","volume":"3","author":"Ulrich","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib9","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1158\/1078-0432.CCR-10-2209","article-title":"Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer","volume":"17","author":"Deenen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","article-title":"MicroRNA functions","volume":"23","author":"Bushati","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nrc2867","article-title":"Genetic variation in microRNA networks: The implications for cancer research","volume":"10","author":"Ryan","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.molmed.2011.04.003","article-title":"MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response","volume":"17","author":"Rukov","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pharmthera.2012.08.016","article-title":"SNPing cancer in the bud: MicroRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer","volume":"137","author":"Salzman","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib15","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1261\/rna.1560209","article-title":"SNPs in human miRNA genes affect biogenesis and function","volume":"15","author":"Sun","year":"2009","journal-title":"RNA"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ng.355","article-title":"Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss","volume":"41","author":"Mencia","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clcc.2015.05.014","article-title":"Biomarkers and molecular imaging as predictors of response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer","volume":"14","author":"Molinari","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib18","first-page":"3761","article-title":"Systematic review of candidate single-nucleotide polymorphisms as biomarkers for responsiveness to neoadjuvant chemoradiation for rectal cancer","volume":"35","author":"Maring","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature07086","article-title":"SMAD proteins control DROSHA-mediated microRNA maturation","volume":"454","author":"Davis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib20","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.18632\/oncotarget.7757","article-title":"Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients","volume":"7","author":"Dreussi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib21","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib22","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-07-0533","article-title":"MicroRNA expression profiling in prostate cancer","volume":"67","author":"Porkka","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","article-title":"MicroRNA signature predicts survival and relapse in lung cancer","volume":"13","author":"Yu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejca.2009.10.027","article-title":"MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types","volume":"46","author":"Hummel","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib25","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib26","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1158\/0008-5472.CAN-09-3541","article-title":"Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility","volume":"70","author":"Nicoloso","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib27","doi-asserted-by":"crossref","first-page":"13653","DOI":"10.1073\/pnas.1103360108","article-title":"Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib28","doi-asserted-by":"crossref","first-page":"7723","DOI":"10.1158\/1078-0432.CCR-11-0990","article-title":"A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer","volume":"17","author":"Smits","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib29","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng1910","article-title":"Natural selection on human microRNA binding sites inferred from SNP data","volume":"38","author":"Chen","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib30","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1186\/1471-2164-12-504","article-title":"A genome-wide survey for SNPs altering microRNA seed sites identifies functional candidates in GWAS","volume":"12","author":"Richardson","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/pgs.10.188","article-title":"Systems pharmacology assessment of the 5-fluorouracil pathway","volume":"12","author":"Muhale","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib32","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.ajpath.2010.12.046","article-title":"The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in\u00a0vitro","volume":"178","author":"Gerhardt","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib33","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/0277-5379(87)90053-8","article-title":"Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity","volume":"23","author":"Peters","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2005.07.027","article-title":"Disorders of purine and pyrimidine metabolism","volume":"86","author":"Nyhan","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1054\/bjoc.2000.1455","article-title":"Bcl-2\/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status","volume":"83","author":"Mirjolet","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib36","doi-asserted-by":"crossref","first-page":"8320","DOI":"10.1038\/sj.onc.1207971","article-title":"Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway","volume":"23","author":"von Haefen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib37","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1038\/onc.2010.181","article-title":"MiR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers","volume":"29","author":"Vetter","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","article-title":"E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer","volume":"28","author":"Schmalhofer","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib40","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/sj.onc.1209859","article-title":"A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth","volume":"26","author":"Rasola","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2017.12.256_bib41","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.2772","article-title":"Beta-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer","volume":"18","author":"Tenbaum","year":"2012","journal-title":"Nat Med"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617344772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617344772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:34:06Z","timestamp":1535157246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617344772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0360301617344772"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.12.256","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of Genetic Variations in MicroRNA Seed Regions With Acute Adverse Events and Survival in Patients With Rectal Cancer Receiving Postoperative Chemoradiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.12.256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}